教育部高层次留学人才、厦门市“双百人才”、厦门市拔尖引进人才。毕业于德国杜塞尔多夫大学，获博士学位。从事肿瘤分子基因学和肿瘤发生发展及转移机制的研究、DNA修复调控异常和肿瘤转移机制的研究。负责及参加多项国际、欧洲及全德肿瘤基础及临床研究，包括全德基因组计划、肿瘤分子靶向药物临床试验及重粒子治疗临床和基础研究。参与的全德遗传性乳腺癌基因学普查及治疗研究，是目前德国该疾病临床治疗的标准基础。率先发现乳腺癌细胞周期激酶CDK4异常。主持/参与国内外重要课题项目9个，包括德国癌症基金会、德国科学技术部基金、国家自然科学基金等。发表多篇高水平SCI论文。

联系方式：anhanxiang@xmu.edu.cn

代表性成果

1. An HX, Claas A, Savelyeva L, Seitz S, Schlag P, Scherneck S, Schwab M. Two regions of deletion in 9p23-24 in sporadic breast cancer. Cancer Res, 1999, 59(16): 3941-3943.

2. Wang LF, Fokas E, Juricko J, You A, Rose F, Pagenstecher A, Engenhart-Cabillic R, An HX. Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. BMC Cancer, 2008, 8: 79.

3. He HT, Fokas E, You A, Engenhart-Cabillic R, An HX. Siah1 proteins enhance radiosensitivity of human breast cancer cells. BMC Cancer, 2010, 10: 403.

4. Dai J, Xu C, Liao L, An H. Climate change and health. Lancet, 2016, 387(10017): 431-2.

5. Cao W, Zhou D, Tang W, An H, Zhang Y. Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation. PeerJ, 2019, 7: e7025.